'Aberrant localisation of Annexin A1 is associated with metastatic outcome in thin melanomas'

Australas J Dermatol. 2020 May;61(2):e254-e256. doi: 10.1111/ajd.13174. Epub 2019 Oct 23.

Authors

Pierre Romero¹, Zied Boudhraa², Matthieu Carton³, Amr Hassan^{1

4}, Juliette Joubert-Zakeyh¹, Bruno Pereira⁵, Pierre Dechelotte¹, Jacques Rouanet⁴, Françoise Degoul²

Affiliations

¹ Department of Pathology, CHU Estaing, Clermont-Ferrand Cedex 1, France.
² UMR990 INSERM, Université d'Auvergne, Clermont-Ferrand, France.
³ Unit of Biometry, Institut Curie, DRCI, PSL Research University, Paris, France.
⁴ Department of Dermatology, CHU Estaing, Clermont-Ferrand Cedex 1, France.
⁵ DRCI, CHRU Gabriel Montpied, Clermont-Ferrand, France.

PMID: 31642517
DOI: 10.1111/ajd.13174

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Annexin A1 / metabolism*
Female
Humans
Male
Melanoma / metabolism*
Melanoma / secondary*
Middle Aged
Retrospective Studies
Skin Neoplasms / metabolism*
Skin Neoplasms / pathology*

Substances

ANXA1 protein, human
Annexin A1